IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
Dated public-record edition

Congressional disclosure brief for April 2, 2023

A permanent snapshot of the disclosure batch indexed for this date. Filing facts, source status, ranges, and limitations remain attached to the underlying receipts.

By PoliWealth Editorial DeskUpdated 2026-07-15 04:30100% official-linked
Share sourced briefDownload daily CSVRead methodology
Receipts
22
Members
1
Tickers
10
Official linked
22 (100%)
Receipt to verify

Virginia Foxx disclosed sell $GSK

Disclosed range $50K – $100K. This is a filing record, not an accusation or investment recommendation.

Official filing linked
Open canonical receipt

Most active tickers in this edition

$VGR4 receipts · 1 members$GSK2 receipts · 1 members$K2 receipts · 1 members$PFF2 receipts · 1 members$SCHD2 receipts · 1 members$PAA2 receipts · 1 members$BCC2 receipts · 1 members$ARLP2 receipts · 1 members
Tomorrow's verified edition

Follow the filing record, not the rumor.

Receive the daily public-record briefing with receipt links and source status. Unsubscribe at any time.